Marek Widera
Works:
- Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
- Cellular and humoral immunity towards parental SARS-CoV-2 and variants of concern after two doses of the NVX-CoV2373-vaccine in comparison to homologous BNT162b and mRNA1273 regimens
- Clinical and virological aspects of HBV reactivation: a focus on acute liver failure
- SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles